Publications by authors named "Gilbert Cote"

95Publications

Advances in Targeting RET-Dependent Cancers.

Cancer Discov 2020 Apr 24;10(4):498-505. Epub 2020 Feb 24.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-19-1116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125013PMC
April 2020

Transcriptional targeting of oncogene addiction in medullary thyroid cancer.

JCI Insight 2018 08 23;3(16). Epub 2018 Aug 23.

Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University Wexner Medical Center and Arthur G. James Comprehensive Cancer Center, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
https://insight.jci.org/articles/view/122225
Publisher Site
http://dx.doi.org/10.1172/jci.insight.122225DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141185PMC
August 2018

A Homozygous RET K666N Genotype With an MEN2A Phenotype.

J Clin Endocrinol Metab 2018 04;103(4):1269-1272

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2017-02402DOI Listing
April 2018

Recent advances and emerging therapies in anaplastic thyroid carcinoma.

F1000Res 2018 18;7. Epub 2018 Jan 18.

Department of Endocrine Neoplasia & Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.13124.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753603PMC
January 2018

Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution.

Surgery 2018 01 6;163(1):212-217. Epub 2017 Nov 6.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.surg.2017.04.044DOI Listing
January 2018

Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.

Thyroid 2017 12;27(12):1523-1533

1 Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University Wexner Medical Center and Arthur G. James Comprehensive Cancer Center , Columbus, Ohio.

View Article

Download full-text PDF

Source
https://www.liebertpub.com/doi/10.1089/thy.2017.0113
Publisher Site
http://dx.doi.org/10.1089/thy.2017.0113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734142PMC
December 2017

Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma.

Ann Clin Lab Sci 2017 Sep;47(5):523-528

School of Health Professions Program in Diagnostic Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057027PMC
September 2017

Genetics of Multiple Endocrine Neoplasia Type 1/Multiple Endocrine Neoplasia Type 2 Syndromes.

Endocrinol Metab Clin North Am 2017 06 18;46(2):491-502. Epub 2017 Mar 18.

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2017.01.011DOI Listing
June 2017

Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.

Thyroid 2017 05 16;27(5):672-681. Epub 2017 Feb 16.

1 Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0395DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802249PMC
May 2017

All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients.

Fam Cancer 2017 04;16(2):283-289

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-016-9948-7DOI Listing
April 2017

Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer.

J Clin Endocrinol Metab 2016 11 30;101(11):4461-4467. Epub 2016 Aug 30.

Department of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.L.M., S.G.W., M.I.H., N.B., C.J., M.E.C., G.J.C., S.I.S.), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030; and Laboratory Medicine (B.H., H.A.F.), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2016-2567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095245PMC
November 2016

Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.

Thyroid 2016 11 18;26(11):1553-1562. Epub 2016 Oct 18.

4 Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center , Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0224DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453497PMC
November 2016

Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma.

Thyroid 2017 01 29;27(1):81-87. Epub 2016 Nov 29.

5 Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center , Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704769PMC
January 2017

Medullary Thyroid Carcinoma Associated with Germline RET Mutation.

Thyroid 2016 12 18;26(12):1744-1751. Epub 2016 Oct 18.

1 Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center , Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175438PMC
December 2016

NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.

Neoplasia 2016 08;18(8):512-23

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2016.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018097PMC
August 2016

Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center.

Horm Cancer 2016 08 16;7(4):279-87. Epub 2016 Jun 16.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, FCT17.6014, Unit 1484, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12672-016-0269-yDOI Listing
August 2016

A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation.

Nat Cell Biol 2016 05 18;18(5):561-71. Epub 2016 Apr 18.

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncb3338DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888794PMC
May 2016

Thyroid C-Cell Biology and Oncogenic Transformation.

Recent Results Cancer Res 2015 ;204:1-39

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1461, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-22542-5_1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640981PMC
March 2016

Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group.

J Clin Endocrinol Metab 2015 Dec 29;100(12):4387-95. Epub 2015 Sep 29.

Mayo Clinic (K.C.B.), Rochester, Minnesota, Minnesota 55905; MD Anderson Cancer Center (G.J.C.), Houston, Texas 77030; Translational Genomics Research Institute (M.J.D.), Phoenix, Arizona 85004; University of Pisa (R.E.), 56126 Pisa, Italy; and The Ohio State University and Arthur G. James Comprehensive Cancer Center (S.J., M.D.R.), Columbus Ohio 43210.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2015-2818DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399506PMC
December 2015

Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene.

Fam Cancer 2015 Dec 11;14(4):615-9. Epub 2015 Jul 11.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street Unit 1461, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-015-9821-0DOI Listing
December 2015

RET fusion as a novel driver of medullary thyroid carcinoma.

J Clin Endocrinol Metab 2015 Mar 29;100(3):788-93. Epub 2014 Dec 29.

Departments of Surgical Oncology (E.G.G., J.B., J.E.L., F.M.-B., N.D.P.), Institute of Personalized Cancer Therapy (P.K.-S.N., K.R.S.), Endocrine Neoplasia and Hormonal Disorders (N.L.B., S.G.W., G.J.C.), Bioinformatics and Computational Biology (K.C.), Hematopathology (X.L.), Investigational Cancer Therapeutics (F.M.-B.), Systems Biology (G.B.M.), and Pathology (M.D.W.), University of Texas MD Anderson Cancer Center, Houston, Texas 77030; Foundation Medicine (G.P., R.Y.), Cambridge, Massachusetts 02141; and Integrative Molecular and Biomedical Sciences Graduate Program (H.L., K.L.S.), Baylor College of Medicine, Houston, Texas 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2014-4153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333032PMC
March 2015

Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer.

J Thorac Oncol 2014 Sep;9(9):1255-63

*Department of Pathology and Molecular Medicine, McMaster University Health Sciences Centre and McMaster University, Hamilton, Ontario; †Department of Pathology, University Health Network, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario; ‡Department of Pathology, Jewish General Hospital and Lady David Institute, McGill University, Montreal, Québec; §Cross Cancer Institute and Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, Alberta; ‖Department of Molecular Pathology, University of Alberta Hospital, Edmonton, Alberta; ¶Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; #Department of Pathology, Aichi Cancer Center Hospital, Nagoya, Japan; **Department of Pathology, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Columbia; ††Department of Pathology, McGill University Health Centre, Montreal, Québec; ‡‡Department of Human Genetics, McGill University, Montreal, Québec; §§Department of Pathology, Health Sciences North, Sudbury, Ontario; ‖‖Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta; ¶¶Department of Pathology, The Ottawa Hospital and University of Ottawa, Ottawa, Ontario; ##Centre hospitalier de l'Universite de Montreal, Montreal, Québec; ***Department of Pathology, London Health Sciences Centre, London, Ontario; †††Department of Molecular Genetics, University of Toronto, Toronto, Ontario; ‡‡‡Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA; §§§Pfizer Oncology Canada, Kirkland, Québec; and ‖‖‖Institut Universitaire de Cardiologie et de Pneumologie de Québec (Hôpital Laval), Université Laval, Québec, Québec.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000239DOI Listing
September 2014

Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma.

Eur J Endocrinol 2014 Sep 2;171(3):R111-22. Epub 2014 Jun 2.

Département de Médecine Nucléaire et de Cancérologie EndocrinienneRadiologie Interventionnelle, Chirurgie, Imagerie, Institut Gustave Roussy, Université Paris Sud, 114 Rue Edouard Vaillant 94805 villejuif Cedex, Paris, France andDepartment of Endocrine Neoplasia and Hormone DisordersUnit 1461, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-14-0113DOI Listing
September 2014

Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism.

J Pediatr Surg 2014 Apr 27;49(4):546-50. Epub 2013 Nov 27.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpedsurg.2013.11.059DOI Listing
April 2014

Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib.

J Clin Endocrinol Metab 2014 Jun 14;99(6):2086-94. Epub 2014 Mar 14.

Departments of Endocrine Neoplasia and Hormonal Disorders (R.D., S.G.W., N.L.B., M.I.H., C.J., M.A.H., R.V.S., A.K.Y., G.J.C., S.I.S., M.E.C.), Diagnostic Radiology (C.D.), and Biostatistics (M.H.), The University of Texas M. D. Anderson Cancer Center; and Department of Endocrinology, Diabetes, and Metabolism (R.D.), Baylor College of Medicine, Houston, Texas 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2013-3588DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037722PMC
June 2014

PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase.

Oncotarget 2014 Feb;5(3):815-23

Department of Neuro-Oncology, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996652PMC
http://dx.doi.org/10.18632/oncotarget.1774DOI Listing
February 2014

Treating medullary thyroid cancer in the age of targeted therapy.

Int J Endocr Oncol 2014;1(2):203-216

Department of Endocrine Neoplasia & Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/ije.14.26DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405124PMC
January 2014

The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.

J Clin Endocrinol Metab 2013 Nov 12;98(11):E1813-9. Epub 2013 Sep 12.

MD, AssociateDepartment of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street Unit 1461, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2013-1653DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399523PMC
November 2013

The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome.

Mol Cancer Res 2013 Aug 3;11(8):815-27. Epub 2013 May 3.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-12-0695DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123851PMC
August 2013

EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.

Mol Cell 2012 Dec 1;48(5):771-84. Epub 2012 Nov 1.

Brain Tumor Center and Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2012.09.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526114PMC
December 2012

Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells.

PLoS One 2012 20;7(7):e41099. Epub 2012 Jul 20.

Department of Endocrine Neoplasia and Hormonal Disorders, MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0041099PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401163PMC
April 2013

Medullary thyroid carcinoma: who's on first?

Thyroid 2012 May;22(5):451-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2012.2205.edDOI Listing
May 2012

Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important.

Surgery 2011 Dec;150(6):1143-52

Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4008, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.surg.2011.09.028DOI Listing
December 2011

PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis.

Mol Carcinog 2012 Nov 4;51(11):895-906. Epub 2011 Oct 4.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.20859DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319169PMC
November 2012

RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase.

Nitric Oxide 2011 Oct 16;25(3):265-74. Epub 2011 Aug 16.

Department of Internal Medicine, University of Texas Health Science Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.niox.2011.08.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190046PMC
October 2011

Management of medullary thyroid carcinoma and MEN2 syndromes in childhood.

Nat Rev Endocrinol 2011 Aug 23;7(10):596-607. Epub 2011 Aug 23.

The Department of Endocrine Neoplasia and Hormonal Disorders, PO Box 301402, Unit 1461, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrendo.2011.139DOI Listing
August 2011

Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

J Clin Endocrinol Metab 2011 Mar 29;96(3):717-25. Epub 2010 Dec 29.

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2010-1946DOI Listing
March 2011

A catecholamine crisis on Mount Kilimanjaro: a hypoxia effect?

J Travel Med 2010 Nov-Dec;17(6):424-6

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1708-8305.2010.00463.xDOI Listing
February 2011

Singular Value Decomposition-based Alternative Splicing Detection.

J Am Stat Assoc 2009 09;104(487):944-953

Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1198/jasa.2009.ap08283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841408PMC
September 2009

Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase.

Mol Cancer Ther 2009 Dec;8(12):3276-84

Department of Pediatrics, Child and Family Research Institute, University of British Columbia, 950 West 28th Avenue, Vancouver, British Columbia, Canada V5Z 4H4.

View Article

Download full-text PDF

Source
http://mct.aacrjournals.org/cgi/doi/10.1158/1535-7163.MCT-09
Publisher Site
http://dx.doi.org/10.1158/1535-7163.MCT-09-0478DOI Listing
December 2009

Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity.

J Clin Endocrinol Metab 2010 Jan 6;95(1):439-44. Epub 2009 Nov 6.

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2009-1485DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805480PMC
January 2010

Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines.

Brain 2009 Aug 8;132(Pt 8):2277-88. Epub 2009 Jun 8.

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awp153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724917PMC
August 2009

Nuclear FISH: automation, analysis, and interpretation.

Authors:
Gilbert B Côté

Diagn Mol Pathol 2009 Jun;18(2):119-24

Genetics Laboratory, Sudbury Regional Hospital, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PDM.0b013e31817dfc65DOI Listing
June 2009

High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma.

J Clin Endocrinol Metab 2008 Nov 2;93(11):4367-72. Epub 2008 Sep 2.

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 433, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.
Publisher Site
http://dx.doi.org/10.1210/jc.2008-0912DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729231PMC
November 2008

Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays.

BMC Genomics 2008 May 12;9:216. Epub 2008 May 12.

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M, D, Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-9-216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410136PMC
May 2008

Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer.

J Clin Endocrinol Metab 2008 Jan 7;93(1):278-84. Epub 2007 Nov 7.

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 435, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.
Publisher Site
http://dx.doi.org/10.1210/jc.2007-1076DOI Listing
January 2008

Surgical management of familial hyperparathyroidism.

Ann Surg Oncol 2007 May 7;14(5):1525-7. Epub 2007 Feb 7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-006-9282-7DOI Listing
May 2007

Invited commentary: medullary thyroid cancer: the importance of RET testing.

Surgery 2007 Jan;141(1):96-9

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.surg.2006.08.016DOI Listing
January 2007

Prenatal cytogenetic assessment and inv(2)(p11.2q13).

Prenat Diagn 2006 Sep;26(9):810-3

Pathology, Montreal Children's Hospital, 2300 Tupper St, Montreal, QC H3H 1P3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pd.1508DOI Listing
September 2006

Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?

J Clin Endocrinol Metab 2006 Aug 30;91(8):2851-8. Epub 2006 May 30.

Instituto Nacional de Cancerología, Fundación Santafé de Bogotá, Colombia, South America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2005-2178DOI Listing
August 2006

Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma.

Mod Pathol 2006 Aug 26;19(8):1034-41. Epub 2006 May 26.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.3800635DOI Listing
August 2006

Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.

World J Surg 2006 May;30(5):643-53

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 444, 1400 Holcombe Boulevard, Houston, Texas 77030-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-006-0360-yDOI Listing
May 2006

RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors.

Thyroid 2005 Jun;15(6):531-44

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2005.15.531DOI Listing
June 2005

Enhancer-dependent splicing of FGFR1 alpha-exon is repressed by RNA interference-mediated down-regulation of SRp55.

Cancer Res 2004 Dec;64(24):8901-5

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 435, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-0716DOI Listing
December 2004

Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.

Hum Mol Genet 2004 Oct 27;13(20):2409-20. Epub 2004 Aug 27.

1Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddh272DOI Listing
October 2004

Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.

J Clin Endocrinol Metab 2004 Aug;89(8):4142-5

The University of Texas MD Anderson Cancer Center, Department of Endocrine Neoplasia and Hormonal Disorders, 1515 Holcombe Boulevard, Unit 435, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-0041DOI Listing
August 2004

A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma.

J Clin Endocrinol Metab 2004 Jul;89(7):3521-6

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 435, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-0073DOI Listing
July 2004

Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain.

Neuro Oncol 2004 Jan;6(1):9-14

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1215/S1152851703000279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871971PMC
January 2004

The role of genetics in the surgical management of familial endocrinopathy syndromes.

J Am Coll Surg 2003 Nov;197(5):818-31

Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.froedtert.com/upload/docs/services/cancer/publica
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S107275150300813
Publisher Site
http://dx.doi.org/10.1016/j.jamcollsurg.2003.07.001DOI Listing
November 2003

Lessons learned from the management of a rare genetic cancer.

N Engl J Med 2003 Oct;349(16):1566-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe038148DOI Listing
October 2003

Polypyrimidine tract-binding protein down-regulates fibroblast growth factor receptor 1 alpha-exon inclusion.

Cancer Res 2003 Oct;63(19):6154-7

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
October 2003

Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.

Arch Surg 2003 Apr;138(4):409-16; discussion 416

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archsurg.138.4.409DOI Listing
April 2003

Maternal serum marker medians in Aboriginal Canadian women.

Prenat Diagn 2003 Feb;23(2):98-100

Genetics, North York General Hospital, 4001 Leslie Street, Toronto, Ontario, M2K 1E1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pd.537DOI Listing
February 2003

Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene.

J Clin Invest 2002 Dec;110(12):1849-57

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI14218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC151647PMC
December 2002

Naturally occurring heterologous trans-splicing of adenovirus RNA with host cellular transcripts during infection.

FEBS Lett 2002 Jul;522(1-3):41-6

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0014-5793(02)02878-8DOI Listing
July 2002

Genotype-phenotype analysis in multiple endocrine neoplasia type 1.

Arch Surg 2002 Jun;137(6):641-7

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archsurg.137.6.641DOI Listing
June 2002